0000000000324942

AUTHOR

Francesco Ceci

0000-0001-9785-5248

showing 6 related works from this author

A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strateg…

2020

Abstract Context The role of immune checkpoint inhibition (ICI) in the treatment of prostate cancer (PC) still remains elusive. It has been proposed that combination of ICI with other molecules increases the efficacy of immunotherapy in PC. Objective To systematically review the literature to assess the potential role of ICI in combination with additional therapies for the management of metastatic castration-resistant PC (mCRPC). Evidence acquisition A systematic review using Medline and scientific meeting records was carried out in September 2020 according to the Preferred Reporting Items for Systematic Review and Meta-analyses guidelines. Ongoing trials of immunotherapy with standard mCRP…

OncologyMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyMEDLINEContext (language use)Androgen deprivation therapy03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingCombination therapies; Immunotherapy; Metastatic castration-resistant prostate cancerImmune Checkpoint Inhibitorsbusiness.industryAndrogen AntagonistsImmunotherapymedicine.diseaseImmune checkpointMetastatic castration-resistant prostate cancerClinical trialRadiation therapyProstatic Neoplasms Castration-ResistantOncology030220 oncology & carcinogenesisSurgeryCombination therapiesImmunotherapybusinessEuropean urology oncology
researchProduct

Choline PET/CT Features to Predict Survival Outcome in High Risk Prostate Cancer Restaging: A Preliminary Machine-Learning Radiomics Study

2020

Background Radiomic features are increasingly utilized to evaluate tumor heterogeneity in PET imaging but to date its role has not been investigated for Cho-PET in prostate cancer. The potential application of radiomics features analysis using a machine-learning radiomics algorithm was evaluated to select 18F-Cho PET/CT imaging features to predict disease progression in PCa. Methods We retrospectively analyzed high-risk PCa patients who underwent restaging 18F-Cho PET/CT from November 2013 to May 2018. 18F-Cho PET/CT studies and related structures containing volumetric segmentations were imported in the "CGITA" toolbox to extract imaging features from each lesion. A Machine-learning model h…

Malemedicine.medical_specialtyn artificial intelligence model demonstrated to be feasible and able to select a panel of 18F-Cho PET/CT features with valuable association with PCa patients' outcome.business.industryProstatic NeoplasmsFeature selectionPet imagingCholine pet ctmedicine.diseaseTumor heterogeneitySurvival outcomeCholineMachine LearningProstate cancerRadiomicsFeature (computer vision)Artificial IntelligencePositron Emission Tomography Computed TomographyMedicineHumansRadiology Nuclear Medicine and imagingRadiologybusinessRetrospective Studies
researchProduct

Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based …

2021

Purpose of review To investigate the features and optimal management of pN+ cM0 prostate cancer (PCa) according to registry-based studies. Recent findings Up to 15% of PCa patients harbor lymph node invasion (pN+) at radical prostatectomy plus lymph node dissection. Nonetheless, the optimal management strategy in this setting is not well characterized. Summary We performed a systematic review including n = 13 studies. Management strategies comprised 13 536 men undergoing observation, 11 149 adjuvant androgen deprivation therapy (aADT), 7,075 adjuvant radiotherapy (aRT) +aADT and 705 aRT. Baseline features showed aggressive PCa in the majority of men. At a median follow-up ranging 48-134mont…

MaleOncologymedicine.medical_specialtyUrologymedicine.medical_treatmentMedizinpopulation-based studiespositive nodesAndrogen deprivation therapyProstate cancerQuality of lifeInternal medicineHumansMedicineStage (cooking)Lymph nodeAdjuvantNeoplasm StagingRetrospective StudiesProstatectomyRadiotherapybusiness.industryProstatectomyProstatic NeoplasmsAndrogen Antagonistslymph nodeProstate-Specific Antigenprostate cancermedicine.diseaseradical prostatectomyProstate-specific antigenmedicine.anatomical_structurelymph node; population-based studies; positive nodes; prostate cancer; radical prostatectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Prostate-Specific Antigen; Prostatectomy; Quality of Life; Radiotherapy Adjuvant; Retrospective Studies; Androgen Antagonists; Prostatic NeoplasmsLymphatic MetastasisQuality of LifeLymph Node ExcisionRadiotherapy AdjuvantLymphadenectomyLymph node; Population-based studies; Positive nodes; Prostate cancer; Radical prostatectomybusinessCurrent Opinion in Urology
researchProduct

Radiation therapy after radical prostatectomy: what has changed over time?

2021

The role and timing of radiotherapy (RT) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) remains controversial. While recent trials support the oncological safety of early salvage RT (SRT) compared to adjuvant RT (ART) in selected patients, previous randomized studies demonstrated that ART might improve recurrence-free survival in patients at high risk for local recurrence based on adverse pathology. Although ART might improve survival, this approach is characterized by a risk of overtreatment in up to 40% of cases. SRT is defined as the administration of RT to the prostatic bed and to the surrounding tissues in the patient with PSA recurrence after surgery but no …

Biochemical recurrenceOncologymedicine.medical_specialtyRD1-811medicine.medical_treatmentMedizinReviewDisease030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinebiochemical recurrencegenomic classifiersmedicineddc:610hormonal therapyProstatectomybusiness.industrysalvage radiotherapyprostate cancermedicine.diseaseRadiation therapyadjuvant radiotherapy; biochemical recurrence; genomic classifiers; hormonal therapy; prostate cancer; salvage radiotherapy030220 oncology & carcinogenesisHormonal therapySurgeryHormone therapybusinessadjuvant radiotherapyAdjuvant
researchProduct

Focal Therapy for Prostate Cancer: Complications and Their Treatment

2021

Focal therapy is a modern alternative to selectively treat a specific part of the prostate harboring clinically significant disease while preserving the rest of the gland. The aim of this therapeutic approach is to retain the oncological benefit of active treatment and to minimize the side-effects of common radical treatments. The oncological effectiveness of focal therapy is yet to be proven in long-term robust trials. In contrast, the toxicity profile is well-established in randomized controlled trials and multiple robust prospective cohort studies. This narrative review summarizes the relevant evidence on complications and their management after focal therapy. When compared to whole glan…

medicine.medical_specialtycomplicationsRD1-811medicine.medical_treatmentMini ReviewMedizinCryotherapyUrinary incontinence03 medical and health sciencesProstate cancer0302 clinical medicinefocal therapyMedicineDysuriaddc:610030212 general & internal medicineExternal beam radiotherapyProspective cohort studybusiness.industryUrinary retentionHIFUmedicine.diseaseprostate cancerSurgeryErectile dysfunctionphotodynamic therapy030220 oncology & carcinogenesiscomplications; cryotherapy; focal therapy; HIFU; photodynamic therapy; prostate cancerSurgerymedicine.symptombusinesscryotherapyFrontiers in Surgery
researchProduct

Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.

2020

Abstract Context Optimal management of prostate cancer (PCa) patients with lymph node invasion at radical prostatectomy and pelvic lymph node dissection still remains unclear. Objective To assess the effectiveness of postoperative treatment strategies for pathologically node-positive PCa patients. The secondary aim was to identify the most relevant prognostic factors to guide the management of pN1 patients. Evidence acquisition A systematic review was performed in January 2020 using Medline, Embase, and other databases. A total of 5063 articles were screened, and 26 studies including 12 537 men were selected for data synthesis and included in the current review according to the Preferred Re…

OncologyBiochemical recurrenceMalemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyContext (language use)PelvisAndrogen deprivation therapy03 medical and health sciencesProstate cancer0302 clinical medicinePositive nodesInternal medicineMedicineHumansRadiology Nuclear Medicine and imagingStage (cooking)ProstatectomyProstate cancerbusiness.industryProstatectomyLymph node; Positive nodes; Prostate cancer; Radical prostatectomyProstatic Neoplasmsmedicine.diseaseRadical prostatectomyRadiation therapySystematic reviewOncology030220 oncology & carcinogenesisLymphatic MetastasisLymph Node ExcisionSurgeryLymph nodebusinessEuropean urology oncology
researchProduct